id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-009230-muvoo3pe	Chen, Zhu	Biomedical science and technology in China	2008-10-17		.txt	text/plain	1276	70	46	Since the mid-1990s, China has used science and education to improve its international competitiveness, 4 with an increase in expenditure on research and development from 0·6% of gross domestic product (GDP) in 1996 to 1·4% in 2006 (a period during which the annual rate of growth in GDP reached more than 9%). While encouraging investigator-initiated projects by augmenting the budget of the National Natural Science Foundation (a fi ve-fold increase over the past decade, rising to 4·3 billion Renminbi [about £0·32 billion] in 2007), China has also launched the national key basic research programme (973) and established major scientifi c facilities, including synchrotron light-sources and centres for genomics or protein science, drug screening, and biodiversity conservation. China is the fi rst country to issue approval through the Government's regulator (the State Food and Drug Administration [SFDA]) for the use of biochips to screen for diseases such as hepatitis C.	./cache/cord-009230-muvoo3pe.txt	./txt/cord-009230-muvoo3pe.txt